Physician Resources: Addressing Behavioral, Social, and Biological Barriers to Optimal Health in Pediatric Obesity and Type 2 Diabetes
In this CME, Mary Ellen Vajravelu, MD, MSHP discusses how to describe the epidemiology and health disparities associated with youth-onset type 2 diabetes and obesity, discuss behavioral economics concepts that are associated with health outcomes in individuals with type 2 diabetes and prediabetes, and review the current state of anti-obesity medication use in youth, including unanswered questions.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the epidemiology and health disparities associated with youth-onset type 2 diabetes and obesity.
- Discuss behavioral economics concepts that are associated with health outcomes in individuals with type 2 diabetes and prediabetes.
- Review the current state of anti-obesity medication use in youth, including unanswered questions.
Mary Ellen Vajravelu, MD, MSHP - Pediatric Endocrinology
Disclosures:
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Available Credit
- 0.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.75 Attendance

Facebook
X
LinkedIn
Forward